Parnell Expands PropofolVet Multidose Offering with New 50 mL Presentation

Larger Format Provides Greater Convenience and Efficiency for Veterinary Practices

OVERLAND PARK, Kan.--(BUSINESS WIRE)-- Parnell today announced the availability of a new 50 mL presentation of PropofolVet Multidose (propofol injectable emulsion), providing veterinary professionals with an additional option to support anesthesia protocols while helping optimize inventory management and reduce waste. The new presentation complements the existing 20 mL offering, extending the reach of Parnell's first generic propofol injectable emulsion for dogs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260728872796/en/

Parnell PropofolVet Multidose 50 mL

PropofolVet Multidose is indicated for use in dogs for induction of anesthesia, maintenance of general anesthesia by intermittent bolus injections for short procedures, and induction of general anesthesia when maintenance is provided by inhalant anesthetics. The new 50 mL presentation is designed to help practices better align product selection with patient volume and workflow needs. Like the existing presentation, the product offers a 28-day in-use shelf life with no refrigeration required, helping veterinary teams maximize product utilization while simplifying storage and handling requirements.

"Veterinary practices continue to look for ways to improve operational efficiency while delivering excellent patient care," said Pablo Lamberto, DVM, U.S. General Manager at Parnell. "By expanding PropofolVet Multidose with a 50 mL presentation, we are giving clinics another tool to support their anesthesia protocols and manage inventory more effectively."

The 50 mL presentation of PropofolVet Multidose further strengthens Parnell's growing anesthesia and sedation portfolio, which includes Dexmedetomidine Hydrochloride Injection, CONTRASED™ (atipamezole hydrochloride), Isoflurane Inhalation Anesthetic, and Sevoflurane Inhalation Anesthetic.

Key Features

• First generic propofol injectable emulsion for dogs
• Now available in two sizes: 50 mL (one per carton) and 20 mL (five per carton)
• 28-day in-use shelf life to maximize use and minimize waste
• Delivers consistent, high-quality induction for reliable procedural control
• No refrigeration required for simplified storage and handling

For more information, visit www.parnell.com or contact your local distributor representative.

Supporting the Whole Team

Parnell's commitment to veterinary teams extends beyond the product. The Foundations of Anesthesia & Sedation Certificate Program, an online course offering 10 RACE-approved CE hours, is designed to build staff competency and confidence in anesthesia protocols. For practices investing in both clinical excellence and team development, the program complements the portfolio as part of a broader support ecosystem. Learn more at parnell.com/education.

About Parnell

Parnell is a veterinary pharmaceutical company focused on developing, manufacturing, and commercializing animal health solutions across anesthesia and beyond. With a strong commitment to quality and customer partnerships, Parnell manufactures and markets products for companion and production animals in 10 countries. Learn more at www.parnell.com.

©2026 Parnell Technologies Pty LTD. CONTRASED is a trademark of Parnell Technologies Pty LTD. MKT-26-146 PC US

View source version on businesswire.com: https://www.businesswire.com/news/home/20260728872796/en/

Media Contact:

Angela Kille
Associate Director of Strategic Marketing
[email protected]
913-274-2100

Source: Parnell

You May Also Be Interested In

• Cyclic Materials’ CEO & Founder Ahmad Ghahreman Shares Insights About Rare Earth Elements on the Impact Podcast with John Shegerian
• Liaison Rebuilds Higher-Education Outreach Around Account-Based Marketing with ZoomInfo
• M6 Métropole Télévision: Formalities for Obtaining the First Half-Year 2026 Financial Report (30 June 2026)